T1期乳腺癌前哨淋巴结转移的影响因素(4)
[13]Kondov B,Kondov G,Spirovski Z,et al.Prognostic factors on the positivity for metastases of the axillary lymph nodes from primary breast cancer[J].Pril(Makedon Akad Nauk Umet Odd Med Nauki),2017,38(1):81-90.
[14]Yoshihara E,Smeets A,Laenen A,et al.Predictors of axillary lymph node metastases in early breast cancer and their applicability in clinical practice[J].Breast,2013,22(3):357-361.
[15]Fujii T,Yajima R,Morita H,et al.Impact of vascular invasion of a primary tumor as a strong risk factor for disease recurrence in patients with node-positive breast cancer[J].Am Surg,2015,81(5):523-526.
[16]吳爽,孙晓,丛斌斌,等.乳腺癌前哨淋巴结活检示踪剂研究进展[J].中国癌症杂志,2019,29(7):540-544.
[17]Giuliano AE,Hunt KK,Ballman KV,et al.Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial[J].JAMA,2011,305(6):569-575.
[18]Giuliano AE,Ballman K,McCall L,et al.Locoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases:long-term follow-up from the American College of Surgeons Oncology Group(Alliance)ACOSOG Z0011 randomized trial[J].Ann Surg,2016,264(3):413-420.
(收稿日期:2019-09-23 本文编辑:任秀兰), 百拇医药(傅成斌 林舜国 许春森 韩晖)
[14]Yoshihara E,Smeets A,Laenen A,et al.Predictors of axillary lymph node metastases in early breast cancer and their applicability in clinical practice[J].Breast,2013,22(3):357-361.
[15]Fujii T,Yajima R,Morita H,et al.Impact of vascular invasion of a primary tumor as a strong risk factor for disease recurrence in patients with node-positive breast cancer[J].Am Surg,2015,81(5):523-526.
[16]吳爽,孙晓,丛斌斌,等.乳腺癌前哨淋巴结活检示踪剂研究进展[J].中国癌症杂志,2019,29(7):540-544.
[17]Giuliano AE,Hunt KK,Ballman KV,et al.Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial[J].JAMA,2011,305(6):569-575.
[18]Giuliano AE,Ballman K,McCall L,et al.Locoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases:long-term follow-up from the American College of Surgeons Oncology Group(Alliance)ACOSOG Z0011 randomized trial[J].Ann Surg,2016,264(3):413-420.
(收稿日期:2019-09-23 本文编辑:任秀兰), 百拇医药(傅成斌 林舜国 许春森 韩晖)